Helene Edmo
Primary Care · Lava Hot Springs, IDNPI 1699767004
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,764 of the $1,979 with a category attached, or 89.1%. 18 manufacturers reported payments, led by AbbVie at 26.7% of the total.
Across 80 payments — averaging $24.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$528
- Inspire Medical Systems, Inc.$487
- Harmony Biosciences LLC$282
- Jazz Pharmaceuticals Inc.$158
- Axsome Therapeutics, Inc.$130
- Novo Nordisk$78
- plus $317 from 12 others
What the payments were for
- Food & beverage$1,76489%
- Education$21511%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $528 |
| Inspire Medical Systems, Inc. | 19 | $487 |
| Harmony Biosciences LLC | 11 | $282 |
| Jazz Pharmaceuticals Inc. | 4 | $158 |
| Axsome Therapeutics, Inc. | 7 | $130 |
| Novo Nordisk | 5 | $78 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $54 |
| Lilly USA, LLC | 3 | $50 |
| Eisai Inc. | 1 | $45 |
| Bristol Myers Squibb | 1 | $33 |
| Amgen | 1 | $22 |
| Ardelyx, Inc. | 1 | $20 |
| Itamar Medical Inc | 1 | $17 |
| ZOLL Respicardia, Inc. | 1 | $16 |
| Averitas Pharma Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$214
How this compares
$1,979 in reported general payments places this provider in the 80th percentile of 48 primary care providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ropinirole Hcl | 24 | $363 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 32 | $220 |
| Lorazepam | 14 | $45 |
Paid to pharmacies, not to this prescriber.
Other primary care in Lava Hot Springs
- Bradley RadfordIdaho Falls$8K
- Kathryn NielsenIdaho Falls$5K
- Jessica ButterfieldBoise$5K
- Teirza BristowKellogg$4K
- Lynnette KhandakerBoise$4K
- Justin RogersIdaho Falls$3K
- Billie Sue MayoNampa$2K
- Marquee RicksRexburg$2K
- Brianna CracoliceNampa$2K
- Julie FrandenMeridian$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.